Dioleoylphosphatidylglycerol Inhibits Heat Shock Protein B4 (HSPB4)-Induced Inflammatory Pathways In Vitro
- Teresa E. Fowler,
- Vivek Choudhary,
- Samuel Melnyk,
- Mishma Farsi,
- Luke Y. Chang,
- Nyemkuna Fortingo
- Augusta University,
- ,
Scholary Output:
Contribution to journal
Article
Research
Peer-reviewOpen access
Sustainable Development Goals
- SDG 3 Good Health and Well
Abstract
<p>Our previous work shows that dioleoylphosphatidylglycerol (DOPG) accelerates corneal epithelial healing in vitro and in vivo by unknown mechanisms. Prior data demonstrate that DOPG inhibits toll-like receptor (TLR) activation and inflammation induced by microbial components (pathogen-associated molecular patterns, PAMPs) and by endogenous molecules upregulated in psoriatic skin, which act as danger-associated molecular patterns (DAMPs) to activate TLRs and promote inflammation. In the injured cornea, sterile inflammation can result from the release of the DAMP molecule, heat shock protein B4 (HSPB4), to contribute to delayed wound healing. Here, we show in vitro that DOPG inhibits TLR2 activation induced in response to HSPB4, as well as DAMPs that are elevated in diabetes, a disease that also slows corneal wound healing. Further, we show that the co-receptor, cluster of differentiation-14 (CD14), is necessary for PAMP/DAMP-induced activation of TLR2, as well as of TLR4. Finally, we simulated the high-glucose environment of diabetes to show that elevated glucose levels enhance TLR4 activation by a DAMP known to be upregulated in diabetes. Together, our results demonstrate the anti-inflammatory actions of DOPG and support further investigation into its development as a possible therapy for corneal injury, especially in diabetic patients at high risk of vision-threatening complications.</p>
Publication Information
Output type
Scholary Output:
Contribution to journal
Article
Research
Peer-reviewOriginal language
English (US)Article number
5839Journal (Volume, Issue Number)
International journal of molecular sciences (Volume 24, Issue 6)Publication milestones
- Published - 03/2023
Publication status
Published - 03/2023
ISSN
1661-6596Publication IDs
- Scopus: 85151111732
- PubMed: 36982926
- ORCID: /0000-0003-3146-162X/work/157545353
Publication metrics
Metrics
Fractional count
3
Fractional count
0.33
Fractional count
6
Fractional count
0.67
Fractional count
3
Fractional count
1
PlumX, opens in new tab
Citation count
3
Captures
10
Mentions
2
Funding Details
This research was funded by the National Eye Institute, grant number #R01EY030576 (to M.A.W. and W.B.B.) and the Veterans Administration, VA Merit Award #I01BX005055 and VA Research Career Scientist Award #IK6BX005691 (to W.B.B.).
FundersFunding numbers
VA Research Career Scientist VA
6BX005691
NEI
01EY030576
VA
01BX005055
